PAREXEL International fourth-quarter consolidated service revenue increases 19.4% to $295.3 million

PAREXEL International Corporation (Nasdaq: PRXL) today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.  

For the three months ended June 30, 2010 consolidated service revenue increased 19.4% to $295.3 million compared with $247.4 million in the prior year period.  Foreign exchange had a minimal impact on revenue on a year-over-year basis.  As was reported one year ago, the financial results for the fourth quarter of Fiscal Year 2009 included a downward adjustment to revenue of $17 million, related to the first nine months of that fiscal year.  Excluding this amount in the prior year, current quarter service revenue would have been up by 11.7%.  Operating income as reported under Generally Accepted Accounting Principles (GAAP) totaled $20.1 million, or 6.8% of consolidated service revenue in the fourth quarter of Fiscal Year 2010, as compared with $19.5 million, or 7.9% of consolidated service revenue, in the comparable quarter of the prior year.  Excluding the impact of restructuring and special charges in the quarter, as detailed in the attached financial tables, operating income was $28.2 million, or 9.6% of consolidated service revenue, in the fourth quarter of Fiscal Year 2010.  GAAP net income for the quarter totaled $12.9 million, or $0.22 per diluted share, compared with net income of $6.3 million, or $0.11 per diluted share, for the quarter ended June 30, 2009.  On an adjusted basis, excluding the impact of restructuring and special charges in the quarter, net income for the fourth quarter was $19.1 million, or $0.32 per diluted share.

Consolidated service revenue for the fourth quarter of Fiscal Year 2010 was $225.4 million in Clinical Research Services (CRS), $31.6 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $38.3 million in Perceptive Informatics, Inc. (PII).

On a GAAP basis for the full fiscal year ended June 30, 2010, consolidated service revenue was $1,131.0 million versus $1,050.8 million in the prior year, a year-over-year increase of 7.6%.  Excluding the positive impact of foreign exchange of $10.3 million in Fiscal Year 2010, revenue increased 6.7% from the prior year.  For Fiscal Year 2010, GAAP operating income was $83.1 million, or 7.3% of consolidated service revenue, compared with GAAP Fiscal Year 2009 operating income of $75.6 million, or 7.2% of consolidated service revenue.  Excluding the impact of certain items as detailed in the attached financial tables in both periods, operating income was $103.5 million, or 9.1% of consolidated service revenue in Fiscal Year 2010, compared with operating income of $90.6 million, or 8.6% of consolidated service revenue in Fiscal Year 2009.  Net income on a GAAP basis for Fiscal Year 2010 was $41.5 million, or $0.71 per diluted share, compared with GAAP net income of $39.3 million or $0.68 per diluted share, in Fiscal Year 2009.  On an adjusted basis, excluding the items noted in the attached financial charts in both periods, net income for the twelve months ended June 30, 2010 was $63.5 million, or $1.08 per diluted share, compared with $47.2 million, or $0.82 per diluted share, in the comparable prior year twelve-month period.

Consolidated service revenue for Fiscal Year 2010 was $870.7 million in CRS, $121.6 million in PCMS, and $138.7 million in Perceptive Informatics, Inc.

The Company reported a Fiscal Year 2010 ending backlog of $2.681 billion, an increase of 23.2% over the ending backlog reported for Fiscal Year 2009.  The reported backlog included record gross new business wins in the quarter of $723.8 million, cancellations of $78.8 million, and a negative impact from foreign exchange rates of $50.1 million.  The net book-to-bill ratio was 2.18 for the quarter, and was 1.53 for Fiscal Year 2010 overall.

Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "Our industry is clearly in a state of change, as clients engage in outsourcing at a more strategic level, and concentrate their outsourced clinical development activities with fewer providers.  I believe that our success in winning significant amounts of new business in Fiscal Year 2010 is a testament to the effectiveness of our strategy.  The combination of strong global capabilities, deep expertise, and industry-leading information technology solutions has resonated strongly with our clients.  We made notable operational improvements during the fiscal year, and we expect continued progress as a result of the investments that we have been making.  Furthermore, we are pleased with the improvement in our tax rate, and we will continue to focus on this area."

With regard to the future outlook for the Company, Mr. von Rickenbach commented, "As we start our new fiscal year, I am excited about the future of our business.  We have a healthy portfolio of pending proposals, and we believe that we are well positioned to continue to capitalize on our success in the marketplace.  In addition, we will remain keenly focused on quality with regard to executing the work that we have won.  We have started to hire and train new employees to support the projects in backlog, which we expect will continue in the first half of the fiscal year.  As a consequence of this recruitment activity and the nature of strategic partnerships, we expect a slower ramp of revenue and earnings in the first half of the fiscal year, and an acceleration in the second half."

The Company issued forward-looking guidance for the first quarter of Fiscal Year 2011 (ending September 30, 2010), and for Fiscal Year 2011.  The Company expects to report consolidated service revenue for the first quarter in the range of $300 to $305 million, and earnings per diluted share in the range of $0.27 to $0.29.   For Fiscal Year 2011, consolidated service revenue is expected to be in the range of $1.265 to $1.310 billion, and earnings per diluted share are projected to be in the range of $1.22 to $1.32.  (Previously issued guidance for Fiscal Year 2011 was for service revenue of $1.245 to $1.290 billion, and earnings per diluted share of $1.20 to $1.32).

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), the Company uses certain non-GAAP financial measures.  The Company believes that presenting the non-GAAP financial measures contained in this press release assists investors and others in gaining a better understanding of its core operating results and future prospects, especially when comparing such results to previous periods or forecasted guidance, because such measures exclude items that are outside of the Company's normal operations and/or, in certain cases, are difficult to forecast accurately for future periods.  Management uses non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring the Company's core operating performance and comparing such performance to that of prior periods and to the performance of its competitors for the same reasons stated above.  Such measures are also used by management in its financial and operating decision-making.  Non-GAAP financial measures are not meant to be considered superior to or a substitute for the Company's results of operations prepared in accordance with GAAP.

SOURCE PAREXEL International Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Parexel. (2010, August 10). PAREXEL International fourth-quarter consolidated service revenue increases 19.4% to $295.3 million. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20100810/PAREXEL-International-fourth-quarter-consolidated-service-revenue-increases-19425-to-242953-million.aspx.

  • MLA

    Parexel. "PAREXEL International fourth-quarter consolidated service revenue increases 19.4% to $295.3 million". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20100810/PAREXEL-International-fourth-quarter-consolidated-service-revenue-increases-19425-to-242953-million.aspx>.

  • Chicago

    Parexel. "PAREXEL International fourth-quarter consolidated service revenue increases 19.4% to $295.3 million". News-Medical. https://www.news-medical.net/news/20100810/PAREXEL-International-fourth-quarter-consolidated-service-revenue-increases-19425-to-242953-million.aspx. (accessed April 26, 2024).

  • Harvard

    Parexel. 2010. PAREXEL International fourth-quarter consolidated service revenue increases 19.4% to $295.3 million. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20100810/PAREXEL-International-fourth-quarter-consolidated-service-revenue-increases-19425-to-242953-million.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PAREXEL introduces new version of Regulatory Information Management platform